| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Oxidation by cytochrome p450 0.8778088549368896 2.4104745494960027 0.0159317828327305 0.9999443615108576 0.8174268920906469 6 Q6UW02,Q16850,O43169 3 |
| Sphingolipid metabolism overview 0.872440314023624 2.3418133001984827 0.0191903118925096 0.999992643086054 0.8174268920906469 8 Q06136,O95470,Q96G23,O15121,P27544 5 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8430092765332596 2.2650729618488907 0.023508202529016 0.9999995012926884 0.8174268920906469 6 Q14739,Q15392,O75845,Q16850 4 |
| Vitamin a and carotenoid metabolism 0.8626669571978873 2.1840316345932 0.0289599235781017 0.9999999836067848 0.8174268920906469 5 Q6NUM9,Q8WTV0 2 |
| Omega3 omega6 fatty acid synthesis 0.8224202196193623 2.1778974441183734 0.0294136728462337 0.9999999876734056 0.8174268920906469 6 O15254,O95864 2 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.8518073207382947 2.1394135740820506 0.0324021885652356 0.9999999981212232 0.8174268920906469 5 P20700,Q03252,O60725 3 |
| Proteoglycan biosynthesis 0.8163600209951223 2.12760627688596 0.0333697413719844 0.9999999989794476 0.8174268920906469 7 Q9NX62,Q8NCH0,Q8TB61 3 |
| Sphingolipid metabolism integrated pathway 0.7942745720296782 1.9849866007349195 0.0471459622929586 0.9999999999998392 0.8174268920906469 9 Q06136,O95470,Q96G23,O15121,P27544 5 |
| Mitochondrial complex iii assembly 0.7883633796465777 1.959200150362867 0.0500893515417737 0.9999999999999756 0.8174268920906469 9 O14949,Q9UDW1,P08574,Q6DKK2,P22695 5 |
| Eicosanoid metabolism via lipooxygenases lox 0.7522624183985573 1.8745656621678628 0.0608525008300078 1.0 0.8174268920906469 6 Q8N8N7,O15254,P09960 3 |
| Familial partial lipodystrophy fpld 0.7605537903169275 1.8609668088424596 0.0627488640209605 1.0 0.8174268920906469 8 P20700,Q03252,O60725,O75844 4 |
| Triacylglyceride synthesis 0.7814733369983332 1.8455037415759952 0.0649642947220945 1.0 0.8174268920906469 5 O00116,Q99943,Q9NUQ2,Q9HCL2 4 |
| Vitamin d metabolism 0.7929922863635024 1.7432683322943796 0.0812867542570781 1.0 0.8174268920906469 4 P38435,Q9UBM7 2 |
| Tyrobp causal network in microglia 0.7219504121186862 1.7406628762324878 0.0817426892090646 1.0 0.8174268920906469 6 Q15418 1 |
| Striated muscle contraction pathway 0.695417342721392 1.5960620806504215 0.1104749336381463 1.0 0.8218436550056972 7 P67936,P09493,Q8WZ42,P08670 4 |
| Sarscov2 and covid19 pathway 0.7473381281140543 1.5543575556770757 0.1200991516411393 1.0 0.8218436550056972 4 Q8WTV0 1 |
| Glycerophospholipid biosynthetic pathway 0.6898344884393939 1.5454471777635463 0.1222381363212448 1.0 0.8218436550056972 8 P48651,Q9BTU6,O00116,Q9Y6K0,Q9HCL2 5 |
| Metabolism of spingolipids in er and golgi apparatus 0.8376373626373632 1.5431422288057977 0.1227962706688161 1.0 0.8218436550056972 3 Q06136,O95470 2 |
| Mitochondrial complex iv assembly 0.7132837705926294 1.5136938198442773 0.1301035131415737 1.0 0.8218436550056972 14 P14406,Q9Y2R0,P09669,Q9Y6N1,P00403,P13073 6 |
| Preimplantation embryo 0.6792415623372906 1.4975683033768492 0.1342454470984591 1.0 0.8218436550056972 8 Q99729,P05023,P51532,Q15717,Q9P0M6,P17096 6 |
| Omega9 fatty acid synthesis 0.6550289006290209 1.4399444468120202 0.1498831168013996 1.0 0.8260093115459538 6 O95864 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.6500461259613556 1.390819495850829 0.1642801696394955 1.0 0.855979265781072 7 P09601,P07099 2 |
| Inclusion body myositis 0.7889193722671464 1.357835732638224 0.1745158137885569 1.0 0.8689086310165478 3 P05067 1 |
| Eicosanoid metabolism via cyclooxygenases cox 0.6325984932051854 1.3379770196082064 0.1809039280968878 1.0 0.8689086310165478 6 Q8N8N7,O15254 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.6671619862499583 1.302827839729147 0.192633543945708 1.0 0.8802515867682449 14 Q16836,O43772 2 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.6357638612960037 1.274717272468468 0.2024093310147763 1.0 0.8802515867682449 9 Q15418 1 |
| Eicosanoid synthesis 0.961274375171656 1.2219086449556116 0.2217421758953759 1.0 0.8802515867682449 2 P09960 1 |
| Cholesterol biosynthesis pathway 0.6487048528946018 1.2181537980283557 0.2231655331755999 1.0 0.8802515867682449 14 Q16850,Q15800,P04035,P37268,Q14534,P48449,O75845 7 |
| 1q211 copy number variation syndrome 0.6189707417475574 1.19803365956467 0.2309039134265031 1.0 0.8850000014923506 9 Q9NPH0 1 |
| Thiamine metabolic pathways 0.6010855754072315 1.194246096539106 0.2323817162589077 1.0 0.8850000014923506 6 O14874,Q9HC21 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6794100937890111 1.178486315130225 0.2386027848497347 1.0 0.8984425849280137 24 P35610,Q14739,O95864,Q16850,Q9UBM7,Q15800,P04035,P37268,Q15392,Q14534,P48449,O75845 12 |
| Estrogen receptor pathway 0.7307695780187268 1.1365662341372114 0.2557196622793023 1.0 0.9175823175904378 3 Q9HCL2 1 |
| Sphingolipid metabolism in senescence 0.6175239439384652 1.0752658290684225 0.2822557303216997 1.0 0.9497299089545148 14 O15269,Q06136,P04062,P16278,Q96G23,P05771,O15121 7 |
| Sphingolipid pathway 0.5937518869715308 1.058427544997078 0.2898605670786187 1.0 0.9497299089545148 10 Q06136,O95470,Q96G23 3 |
| Influence of laminopathies on wnt signaling 0.5943389057346714 1.014023919915054 0.3105713386447477 1.0 0.9643670304639068 12 P50402,O60725,P02545,O75844 4 |
| Nipbl role in dna damage cornelia de lange syndrome 0.6167614916619009 1.0092155079647749 0.312871290800321 1.0 0.9643670304639068 4 Q14676,Q6KC79 2 |
| Mitochondrial immune response to sarscov2 0.5737775963959117 0.9677573463912602 0.3331655705437133 1.0 0.9720226625033032 10 Q9Y6M9 1 |
| Tryptophan metabolism 0.5905355516223307 0.9523346895111584 0.3409272702699235 1.0 0.9720226625033032 14 Q16836,Q15392,P51648 3 |
| Ccl18 signaling pathway 0.5743543609852069 0.9465964193957114 0.3438444691958449 1.0 0.9720226625033032 11 Q96GC9,Q86UE4,P08670 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6016855114677737 0.9411007615237518 0.3466532253392471 1.0 0.9720226625033032 17 Q9Y2U8,P55209,O60725,P42167,P50402,O75844 6 |
| Nuclear receptors in lipid metabolism and toxicity 0.8648722878330128 0.8903724475319115 0.3732659317297162 1.0 0.9720226625033032 2 P28288 1 |
| Drug induction of bile acid pathway 0.8648722878330111 0.8903724475319069 0.3732659317297186 1.0 0.9720226625033032 2 O15439 1 |
| 15q112 copy number variation syndrome 0.5582475181567549 0.8796101208586016 0.3790705542098713 1.0 0.9720226625033032 5 Q96CW5,Q7L576,Q06787 3 |
| Bdnftrkb signaling 0.5531582079688672 0.8749173723315679 0.3816188658706454 1.0 0.9720226625033032 10 Q15334,Q15418 2 |
| Urea cycle and related diseases 0.8511397967591326 0.8445968748847543 0.3983359545016536 1.0 0.9720226625033032 2 Q9Y619 1 |
| Vitamin d receptor pathway 0.5481748065806151 0.806326771697289 0.4200544578916183 1.0 0.9720226625033032 12 Q92604,Q96KA5,P08183,Q5VV42,P09493,P20020 6 |
| Insulin signaling in adipocytes diabetic condition 0.5635471604236366 0.792653709865198 0.4279796068981378 1.0 0.9720226625033032 4 P62753 1 |
| Insulin signaling in adipocytes normal condition 0.5635471604236366 0.792653709865198 0.4279796068981378 1.0 0.9720226625033032 4 P62753 1 |
| Proximal tubule transport 0.5435243969783667 0.7857405994202675 0.4320194727849986 1.0 0.9720226625033032 12 P05023,P08183,Q9Y5K8,P04920,O15439 5 |
| Oxidative stress response 0.5195047140588993 0.7741345431013938 0.4388512319150837 1.0 0.9720226625033032 8 P09601,P10620 2 |
| Metapathway biotransformation phase i and ii 0.5823447165749768 0.7630776727808742 0.4454170746760195 1.0 0.9720226625033032 22 Q7LGA3,P21964,Q16850,P07099,P10620,Q8NCH0,Q6UW02 7 |
| Progeriaassociated lipodystrophy 0.5356467894606355 0.751059968214728 0.4526165663465757 1.0 0.9720226625033032 12 P20700,Q03252,O60725,O75844 4 |
| Electron transport chain oxphos system in mitochondria 0.6233872479594844 0.7290631861913898 0.4659630123227241 1.0 0.9720226625033032 55 P18859,P12236,P14406,O14548,P09669,O43676,P12235,P14927,Q9Y6N1,O75306,Q9UDW1,P13073,P56385,O14949,O96000,Q9Y6M9,P03886,P06576,O95168,P05141,P21912,O75964,P22695,O75438,O75880,P00403,P24539 27 |
| Arrhythmogenic right ventricular cardiomyopathy 0.527595456073559 0.7158898994300155 0.4740593357626586 1.0 0.9746413321526084 12 P50402,P02545,P16615 3 |
| Fatty acid betaoxidation 0.5540854043745742 0.6903617760453687 0.489966708064238 1.0 0.982937421027434 19 Q16836,P23786,O43772 3 |
| Glucocorticoid receptor pathway 0.4885868821599474 0.6895263974600909 0.4904920672690824 1.0 0.982937421027434 6 P27105 1 |
| Disruption of postsynaptic signaling by cnv 0.4941017122137233 0.6638064899386904 0.5068141713956027 1.0 1.0 8 Q14168,Q7L576 2 |
| Endothelin pathways 0.5015984431238546 0.6489328109919029 0.516381805730413 1.0 1.0 10 P42892,P16615 2 |
| Nocgmppkg mediated neuroprotection 0.4838478928643352 0.6443185085303076 0.5193689160441224 1.0 1.0 7 Q15334,P30536 2 |
| Kennedy pathway from sphingolipids 0.4667912507021742 0.5969002551644593 0.5505739769193811 1.0 1.0 6 Q9Y6K0 1 |
| Ppar signaling pathway 0.5341875345614154 0.5870455888206161 0.5571730891682058 1.0 1.0 20 P23786,O95864,Q15067,O15254,P48163 5 |
| Adipogenesis 0.515152791186747 0.5800425321585279 0.5618859361692612 1.0 1.0 16 P14174,O00767,P43490,O75844 4 |
| Ketogenesis and ketolysis 0.4652908317897601 0.5665286350691925 0.5710344727378884 1.0 1.0 7 P23786,O43772,P53985 3 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.569052711771201 0.5533310047253149 0.5800367741561305 1.0 1.0 3 Q15758 1 |
| Copper homeostasis 0.4754181418235607 0.5396308202681129 0.5894516574400575 1.0 1.0 10 Q9Y6N1,P78536,P05067 3 |
| Ferroptosis 0.5292512762707937 0.5020727080945572 0.6156163771870271 1.0 1.0 24 P09601,P45880,P04035,P37268,P16435,Q9Y277,Q15043 7 |
| Mitochondrial complex i assembly model oxphos system 0.5394859945721008 0.4885776506087935 0.625140738933365 1.0 1.0 28 Q9P0J0,Q9Y6M9,P03886,O43676,O95168,Q8IUX1,O96000,O75438 8 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.4421348600444798 0.4731608321426321 0.6360984393350559 1.0 1.0 7 P18206,P12814,P19174,Q07157 4 |
| Glycosaminoglycan degradation 0.4320594181398348 0.4564854313600279 0.6480409447421798 1.0 1.0 6 P15586 1 |
| Nephrogenesis 0.7011809942323501 0.3957692698708356 0.6922752487944552 1.0 1.0 2 Q04721 1 |
| Oxidative phosphorylation 0.5080076320887491 0.3165838586480513 0.7515593851906026 1.0 1.0 32 P18859,Q9Y6M9,P03886,Q86Y39,P56385,O75306,P06576,O95168,P56134,O96000,O75964,P24539,O75438 13 |
| Nephrotic syndrome 0.4420031844907297 0.3152419922057005 0.7525779245534914 1.0 1.0 15 P02545,Q14108,O75844,O43707,Q9BT22 5 |
| Pparalpha pathway 0.3951811870729022 0.2818629132020249 0.7780486279576371 1.0 1.0 8 P06493,P23786,P11802 3 |
| Nonalcoholic fatty liver disease 0.526725351335055 0.2618694211902049 0.7934221154971177 1.0 1.0 57 Q9P0J0,P14406,Q9Y6M9,Q86Y39,P09669,O43676,O14949,P00403,Q9UDW1,O95168,Q96GC9,P08574,P13073,Q9NX14,O96000,P22695,O75438 17 |
| 7oxoc and 7betahc pathways 0.3930688480233173 0.2567849120932521 0.7973448180316791 1.0 1.0 9 O14975,O15118,Q9Y305,Q9UBM7 4 |
| Pregnane x receptor pathway 0.3747626147794438 0.2534420727312587 0.7999266192946641 1.0 1.0 6 O15439 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.4418865504897059 0.2373419282733094 0.8123915371223076 1.0 1.0 20 Q14739,Q9Y2U8,P42167,P50402,O94901 5 |
| Gastric cancer network 2 0.4212414134519922 0.2304255204986537 0.8177611321512028 1.0 1.0 16 Q14739,Q86UE4 2 |
| Fatty acid transporters 0.3697086311160054 0.1971987739248542 0.8436719900438268 1.0 1.0 5 O95573,P33121,Q6P1M0,O60488 4 |
| Camkk2 pathway 0.3978238714849505 0.1900123410584467 0.8492994599409669 1.0 1.0 14 P09601 1 |
| Spinal cord injury 0.4229962578431921 0.1793659439565493 0.8576503704896481 1.0 1.0 20 P14174,Q9NQC3 2 |
| Nanoparticle triggered autophagic cell death 0.3492750156341012 0.1627799936212311 0.8706916609325095 1.0 1.0 7 Q96GC9 1 |
| Thermogenesis 0.4587291299529905 0.1590317616642382 0.8736438500741663 1.0 1.0 31 Q15418,O43772,P51812 3 |
| Glycosylation and related congenital defects 0.3636505691167316 0.1551850901776014 0.8766754022048815 1.0 1.0 10 Q9H6U8,Q2TAA5,Q9BT22 3 |
| Allograft rejection 0.3613806434377259 0.1351953597270608 0.8924574158133731 1.0 1.0 11 P08670,P10321,P08183,Q9BY49 4 |
| Imatinib and chronic myeloid leukemia 0.3927305281071952 0.1239194451791483 0.9013790565901414 1.0 1.0 3 P08183 1 |
| Cohesin complex cornelia de lange syndrome 0.3846492858554958 0.1027178961209145 0.9181868697246536 1.0 1.0 18 Q8N3U4,Q6KC79,Q14738,Q15257,P30154,Q29RF7,Q9UQE7,Q9NTI5,P06493,Q14683 10 |
| Sarscov2 b117 variant antagonises innate immune activation 0.3706043956043975 0.095977046578954 0.9235388025664356 1.0 1.0 3 Q9UHD2,Q7Z434 2 |
| Histone modifications 0.3586787586889305 0.0905829157203465 0.9278240073965052 1.0 1.0 14 Q01105,Q03164,P62805 3 |
| Serine metabolism 0.3045278218848835 0.0757284956361771 0.9396351048430632 1.0 1.0 6 P00374 1 |
| Glial cell differentiation 0.4924471299093559 0.0619439045120111 0.9506075038627044 1.0 1.0 2 P26038 1 |
| Ovarian infertility 0.3304822083899834 0.0598647123653074 0.9522633849194811 1.0 1.0 3 P11802 1 |
| Notch signaling 0.3124189182812121 0.0458975682908321 0.96339189235927 1.0 1.0 10 P78536 1 |
| Hair follicle development organogenesis part 2 of 3 0.2703296703296727 0.0334033661773395 0.9733529253408464 1.0 1.0 3 Q9BZE4,P35222 2 |
| Wntbetacatenin signaling pathway in leukemia 0.2355042594119364 0.0290212195958831 0.976847666930545 1.0 1.0 4 P14923,P35222,P48729 3 |
| Fbxl10 enhancement of maperk signaling in diffuse large bcell lymphoma 0.2880330123796512 0.0281741779641724 0.9775232320460074 1.0 1.0 8 Q99496,P27361,P28482,O75367,Q9P0M6,O75530,Q15022 7 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.2354395604395628 0.0276978068061332 0.9779031729490212 1.0 1.0 3 P35222,P48729 2 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.2570800109980793 0.0078217678154701 0.99375919585737 1.0 1.0 6 P06400,Q15648,O75367,P35222,P11802 5 |
|
|
